AI Adoption in Healthcare Is Accelerating—But Clinicians Are Sounding an Alarm
A Profession at an Inflection Point
Artificial intelligence has moved from novelty to near-ubiquity in clinical settings with a velocity that has outpaced institutional readiness. According to the 2026 Future Ready Healthcare Survey Report, released June 2, 2026 by Wolters Kluwer Health and conducted in partnership with the independent research firm Ipsos, the proportion of physicians using AI at least once per week has nearly doubled in a single year. This extraordinary rate of adoption carries with it an equally extraordinary set of professional and ethical challenges—challenges that now demand the focused attention of practicing clinicians, healthcare administrators, and clinical leaders alike.
The survey, which drew responses from 355 healthcare professionals (203 physicians and 152 nurses) and 254 patients across the United States, offers the most granular picture yet of how both sides of the clinical encounter are integrating—and contending with—AI in their daily lives.
The Scale of Adoption: Remarkable and Rapid
Nearly three-quarters of physicians and 70% of nurses reported using AI at least once a week for clinical work—a figure dramatically higher than the prior year, when 38% of doctors and 46% of nurses reported the same. This is not incremental change; it is a fundamental shift in how medicine is being practiced, information is being sought, and decisions are being made.
Wolters Kluwer's Chief Medical Officer, Dr. Peter Bonis, characterized the surge as a product of both greater exposure and growing familiarity with the tools themselves: "I think it's a combination of increased exposure, increased familiarity."
Patients, too, are arriving to clinical encounters increasingly pre-informed by AI. Nearly one in three patients (28%) reported that AI explains medical information more clearly than traditional health websites, and nearly one in five (19%) indicated that AI provides answers to health questions faster than waiting for a clinician's response. During medical appointments, nearly 60% of patients said their clinicians openly engaged with AI-generated information they brought to the visit.
The Trust Gap: Where Adoption and Confidence Diverge
Despite this accelerating integration, the survey reveals a widening chasm between AI utilization and institutional confidence in that utilization. Four principal concerns dominate clinician responses.
Deskilling: The Most Pressing Professional Risk
A full 74% of clinicians expressed concern about "deskilling"—defined as an increasing overreliance on AI tools that progressively diminishes clinicians' capacity to independently identify inaccuracies or critically evaluate AI-generated recommendations. This concern is not merely theoretical. As AI systems supply clinical reasoning in packaged, authoritative-seeming formats, the cognitive engagement required of the clinician may be reduced, eroding the very skills that training and experience are designed to build.
The survey identified transparent reasoning displays as a critical safeguard: approximately 53% of clinicians stated they want AI to be required to disclose the detailed reasoning behind its responses. Encouragingly, a strong majority of physicians reported maintaining verification habits—77% said they cross-check AI answers against original sources or trusted clinical databases such as PubMed or UpToDate, and 78% of patients now actively expect clinicians to perform this verification.
Hallucinations: Fabricated Evidence Entering the Point of Care
Three-quarters of clinicians (74%) cited AI hallucinations—instances in which the technology generates fabricated or factually incorrect information, including fictitious medical studies—as a major concern affecting their ability to practice safely. While 73% reported confidence in their ability to identify clinically invalid responses without external consultation, this figure carries a sobering corollary: approximately one in four U.S. clinicians are uncertain whether they could detect erroneous AI-generated medical information without cross-referencing a trusted source.
Advertiser Bias: The Monetization of Clinical Advice
Nearly three out of four clinicians (72%) and three out of five patients (61%) expressed concern that AI-generated clinical information sponsored by advertisers—including pharmaceutical and medical device companies—could introduce commercial bias into healthcare decision-making. This concern reflects an awareness that the business models of certain AI platforms may be structurally misaligned with the obligations of clinical neutrality.
Accountability in the Event of Harm
A full 75% of patients reported concern about accountability when AI contributes to harm in the care process. The legal, ethical, and professional dimensions of AI-assisted adverse outcomes remain largely unresolved, and the survey findings suggest that neither clinicians nor patients feel these questions have been adequately addressed at the institutional or regulatory level.
Governance: A Critical Lag
Perhaps the most structurally alarming finding in the report pertains not to AI itself but to the frameworks designed to govern its use.
"The pressure is on healthcare leaders now to close the trust gap with visible, organizational governance and trusted content that tackles these worries, while continuing to drive innovative new clinical solutions." — Greg Samios, CEO, Wolters Kluwer Health
Despite rapid AI adoption across healthcare settings, awareness among physicians and nurses of formal AI governance policies in their own organizations rose only marginally year over year—from 21% in 2025 to a still modest 27% in 2026. This figure suggests that governance programs either do not exist in most healthcare organizations, or that where they do exist, they are failing to reach the clinicians who most need to understand them.
A well-functioning governance framework is not merely a policy document; it is a communicated, internalized, and operationally reinforced system. By that standard, most healthcare organizations appear to be operating in a governance deficit precisely at the moment when AI's clinical influence is at its most pronounced.
The Case for Human Validation: A Unified Mandate
Despite their divergent pathways into AI, patients and clinicians converge on one central demand: humans must remain in the loop.
"AI is not just something that healthcare organizations are implementing within the walls of the health system. It's something that's shaping the patient journey well before they enter the doctor's office. That influences the dynamics of clinical decision-making in important ways." — Dr. Peter Bonis, MD, Chief Medical Officer, Wolters Kluwer Health
More than 90% of clinicians and 89% of patients indicated they believe human experts should be validating the sources behind AI-generated healthcare content used for patient care. This is not a rejection of AI; it is a principled demand for accountability structures that acknowledge the irreplaceable role of clinical expertise, lived experience, and professional judgment in the care process.
On a note of carefully calibrated optimism, 70% of both patients and clinicians believe AI has meaningful potential to improve patient health literacy and engagement. The technology is not perceived as adversarial—but it is perceived as requiring robust human oversight to realize its promise without compounding its risks.
Implications for Clinical Practice and Health System Leadership
The findings of the 2026 Future Ready Healthcare Survey carry direct implications for physicians in private practice and clinical leaders across organizational settings:
First, the deskilling concern warrants deliberate clinical countermeasures. Independent case reasoning, peer consultation, and routine verification against primary literature are not redundant habits in an AI-augmented practice—they are essential protective behaviors.
Second, the governance gap represents an actionable administrative priority. Healthcare organizations that have not yet established, formalized, and actively communicated AI governance policies are operating at both institutional and clinical risk. The survey data suggests this is the majority of American healthcare organizations.
Third, the patient-side data reframes AI not merely as a back-office workflow tool, but as an active participant in the patient journey well before the clinical encounter. Physicians who fail to anticipate AI-informed patient expectations may find themselves at a communicative disadvantage.
"The report's findings expose an important reality bubbling to the surface of the AI conversation: real-world use of AI is rising year-over-year by both patients and clinicians, but it comes with a significant trust gap over mounting concerns around AI hallucinations, bias, and the monetization of personal data." — Greg Samios, CEO, Wolters Kluwer Health
The coming years will likely define whether AI in healthcare fulfills its transformative promise or produces a generation of clinicians whose diagnostic independence has been quietly attenuated by the tools designed to support them. The data are in. The question now is whether the profession will respond with the same urgency.
.png)
.png)
.png)
.png)
.png)